Hologic Announces Financial Results for First Quarter of Fiscal 2016
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Supermicro probe finds no senior management link to export violations
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
Leerink Partners Remains Bullish on Hologic (HOLX) as Lower Tax Rate Helps Drive 1Q Results
January 28, 2016 9:31 AM ESTLeerink Partners maintained an Outperform rating on Hologic (NASDAQ: HOLX), and cut the price target to $44.00 (from $47.00), following the company's 1Q earnings report. HOLX reported revenue of $695M, which was $6M ahead of the Street's estimate, with outperformance primarily from GYN and... More
Needham & Company Upgrades Hologic (HOLX) to Buy
January 28, 2016 7:30 AM ESTNeedham & Company upgraded Hologic (NASDAQ: HOLX) from Hold to Buy with a price target of $41.00.
Analyst Mike Matson commented, "HOLX's F1Q16 revenue and EPS beat consensus. Management lowered its FY16 revenue guidance due to currency but raised its EPS... More
Hologic (HOLX) Tops Q1 EPS by 4c; Guides FY EPS Higher
January 27, 2016 4:07 PM ESTHologic (NASDAQ: HOLX) reported Q1 EPS of $0.46, $0.04 better than the analyst estimate of $0.42. Revenue for the quarter came in at $695.2 million versus the consensus estimate of $688.04 million.
GUIDANCE:
Hologic sees Q2 2016 EPS of $0.45-$0.46, versus the consensus of $0.45. Hologic sees Q2... More
